Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-17

Clinical Trial Update: A Study of Brenipatide in Participants With Alcohol Use Disorder [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating Brenipatide for alcohol use disorder is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Brenipatide

Snippet

Sponsor: Eli Lilly and Company | Conditions: Alcohol Use Disorder | Phase 3 | Status: RECRUITING